MIRA Pharmaceuticals Inc. (MIRA)
NASDAQ: MIRA
· Real-Time Price · USD
1.62
-0.18 (-10.00%)
At close: Oct 17, 2025, 3:59 PM
1.60
-1.23%
After-hours: Oct 17, 2025, 07:57 PM EDT
MIRA Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
Revenue | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | 8.53M | n/a | n/a |
Gross Profit | n/a | -8.53M | n/a | n/a |
Operating Income | -8.02M | -8.53M | -7.05M | -2.15M |
Interest Income | n/a | n/a | n/a | n/a |
Pretax Income | -7.85M | -11.98M | -7.06M | -2.18M |
Net Income | -7.85M | -11.98M | -7.06M | -2.18M |
Selling & General & Admin | 4.71M | 6.95M | 2.99M | 770.12K |
Research & Development | 3.31M | 1.57M | 2.35M | 684.45K |
Other Expenses | n/a | 0.00 | -1.7M | -697.6K |
Operating Expenses | 8.02M | 8.53M | 7.05M | 2.15M |
Interest Expense | 165.67K | 3.46M | 10.25K | 24.37K |
Selling & Marketing Expenses | n/a | 453.55K | n/a | n/a |
Cost & Expenses | n/a | 8.53M | 7.05M | 2.15M |
Income Tax Expense | n/a | n/a | -7.05K | -2.15K |
Shares Outstanding (Basic) | 15.44M | 18.57M | 14.75M | 14.75M |
Shares Outstanding (Diluted) | 15.44M | 18.57M | 14.75M | 14.75M |
EPS (Basic) | -0.51 | -0.65 | -0.48 | -0.15 |
EPS (Diluted) | -0.51 | -0.65 | -0.48 | -0.15 |
EBITDA | -7.85M | n/a | -7.05M | -2.15M |
EBIT | -7.69M | -8.53M | -7.05M | -2.15M |
Depreciation & Amortization | -165.67K | 8.53M | 7.05M | 2.15M |
Source: Financial Modeling Prep. Financial Sources.